Ludwig Chicago nanotechnology induces therapeutic immune responses against multiple types of tumors

A Ludwig Cancer Research study has developed a novel nanotechnology that triggers potent therapeutic anti-tumor immune responses and demonstrated its efficacy in mouse models of multiple cancers.

Related Keywords

Wenbin Lin ,Kaiting Yang ,Ralph Weichselbaum ,Emily Henderson ,Ludwig Center At Chicago ,Lab Diagnostics Automation ,Chicago Center Weichselbaum ,Lab Diagnostics Automation Industry ,A Ludwig Cancer Research ,Ludwig Cancer Research ,Co Director Ralph Weichselbaum ,Ludwig Center ,Chicago Center Co Director ,Automation Industry Focus ,Nanotechnology ,Flood ,Blood Vessels ,Dancer ,Cancer Therapy ,Fell ,Gold ,Na ,Efficacy ,Genes ,Immunity ,Immunotherapy ,Interferon ,Anoparticle ,Anoparticles ,Pancreatic Cancer ,Pd L1 ,Reclinical ,Protein ,Radiotherapy ,Research ,Humor ,